HOME › DRUGS › MEPOLIZUMAB
ACTIVE SUBSTANCE / INN

MEPOLIZUMAB

Brand name(s): Bosatria, Nucala, NUCALA
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
BLA125526
Asthma
ACTIVE SUBSTANCE
Mepolizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited, GLAXOSMITHKLINE LLC, Glaxo Group Limited
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NUCALABLA125526GLAXOSMITHKLINE LLCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NucalaGlaxoSmithKline Trading Services LimitedAuthorised01/12/2015Asthma
BosatriaGlaxo Group LimitedApplication withdrawnHypereosinophilic Syndrome

FULL INTELLIGENCE ON MEPOLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →